Kardigan, Inc. (KARD)
21.92
+2.32
(+11.84%)
USD |
NASDAQ |
Sep 02, 16:00
21.88
-0.04
(-0.18%)
After-Hours: 20:00
Kardigan Enterprise Value : 1.465B for Sept. 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 1.465B |
| September 01, 2026 | 1.248B |
| August 31, 2026 | 1.300B |
| August 28, 2026 | 1.287B |
| August 27, 2026 | 1.360B |
| August 26, 2026 | 1.395B |
| August 25, 2026 | 1.371B |
| August 24, 2026 | 1.345B |
| August 21, 2026 | 1.380B |
| August 20, 2026 | 1.309B |
| August 19, 2026 | 1.473B |
| August 18, 2026 | 1.371B |
| August 17, 2026 | 1.337B |
| August 14, 2026 | 1.304B |
| August 13, 2026 | 1.454B |
| August 12, 2026 | 1.451B |
| August 11, 2026 | 1.478B |
| August 10, 2026 | 1.386B |
| August 07, 2026 | 1.332B |
| August 06, 2026 | 1.319B |
| August 05, 2026 | 1.308B |
| August 04, 2026 | 1.331B |
| August 03, 2026 | 1.282B |
| July 31, 2026 | 1.362B |
| July 30, 2026 | 1.329B |
| Date | Value |
|---|---|
| July 29, 2026 | 1.260B |
| July 28, 2026 | 1.378B |
| July 27, 2026 | 1.400B |
| July 24, 2026 | 1.354B |
| July 23, 2026 | 1.441B |
| July 22, 2026 | 1.552B |
| July 21, 2026 | 1.557B |
| July 20, 2026 | 1.416B |
| July 17, 2026 | 1.391B |
| July 16, 2026 | 1.380B |
| July 15, 2026 | 1.471B |
| July 14, 2026 | 1.496B |
| July 13, 2026 | 1.615B |
| July 10, 2026 | 1.718B |
| July 09, 2026 | 1.701B |
| July 08, 2026 | 1.493B |
| July 07, 2026 | 1.643B |
| July 06, 2026 | 1.638B |
| July 02, 2026 | 1.692B |
| July 01, 2026 | 1.669B |
| June 30, 2026 | 1.645B |
| June 29, 2026 | 2.638B |
| June 26, 2026 | 2.433B |
| June 25, 2026 | 2.342B |
| June 24, 2026 | 2.292B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 691.05B |
| Bristol Myers Squibb Co. | 172.22B |
| Crinetics Pharmaceuticals, Inc. | 7.830B |
| ANI Pharmaceuticals, Inc. | 1.913B |
| Corcept Therapeutics, Inc. | 11.62B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -116.24M |
| Total Expenses (Quarterly) | 116.24M |
| EPS Diluted (Quarterly) | -1.244 |
| Earnings Yield | -12.39% |
| Normalized Earnings Yield | -10.76 |